Denali Therapeutics Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-01. The offering totals $499.7M, of which $499.7M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Jennifer O Cook | Director | South San Francisco, CA |
| Jay T Flatley | Director | South San Francisco, CA |
| Erik T Harris | Director | South San Francisco, CA |
| Peter S Klein | Director | South San Francisco, CA |
| Steve E Krognes | Director | South San Francisco, CA |
| Vicki L Sato | Director | South San Francisco, CA |
| David P Schenkein | Director | South San Francisco, CA |
| Marc P Tessier-Lavigne | Director | South San Francisco, CA |
| Nancy A Thornberry | Director | South San Francisco, CA |
| Ryan Watts | Director | Seattle, WA |
| Carole O Ho | Executive Officer | South San Francisco, CA |
| Alexander O Schuth | Executive Officer | South San Francisco, CA |
| Ryan Watts | Executive Officer | Seattle, WA |